GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status:
Completed
Trial end date:
2011-01-18
Target enrollment:
Participant gender:
Summary
This study will determine the safety, tolerability and efficacy of GSK1322322 verses
Linezolid in subjects with Acute Bacterial Skin and Skin Structure Infection (ABSSSI).